Sponsor

Hermes Pharma GmbH

Germany Georg-Kalb-Strasse 5, Grosshesselohe, Großhesselohe, 82049, Germany

About the sponsor

Clinical research includes dimenhydrinate products intended for the prophylaxis and symptomatic treatment of nausea and vomiting, with particular relevance to kinetosis and other causes of motion-related discomfort.

Antiemetic treatment
Motion sickness
Nausea control

The sponsor’s work in this area centers on oral formulations used for relief of acute vestibular and gastrointestinal symptoms.

About Specializations

Hermes Pharma GmbH runs clinical trials in conditions such as Prophylaxis against motion sickness, Motion sickness, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Prophylaxis against motion sickness+1

Not recruiting

Bioavailability of 50 mg dimenhydrinate granules taken with or without water versus reference formulations for nausea and vomiting in healthy volunteers

Registered drugNo placebo